Colecalciferol - Abiogen Pharma

Drug Profile

Colecalciferol - Abiogen Pharma

Alternative Names: 7-Dehydrocholesterol; Cholecalciferol; Deltius; Dibase; Thorens; VD3; Vitamin-D3

Latest Information Update: 19 Oct 2016

Price : $50

At a glance

  • Originator Abiogen Pharma
  • Developer Abiogen Pharma; Italfarmaco
  • Class Adjuvants; Cholestenes; Osteoporosis therapies; Small molecules; Sterols; Vitamin D analogues
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Vitamin D deficiency

Most Recent Events

  • 13 Sep 2014 Launched for Vitamin D deficiency in Spain (PO, Drops), (PO, Liquid) before September 2014 (AEMPS website)
  • 14 Feb 2014 Registered for Vitamin D deficiency in Ireland (PO)
  • 17 Jan 2014 Registered for Vitamin D deficiency in Spain (PO, Drops)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top